Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gadow, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gadow, K. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pharmacotherapy for Behavior Disorders

Typical Treatment Practices

Kenneth D. Gadow, Ph.D.

Office of Special Education, State University of New York, Stony Brook, New York

The parents and teachers of 100 children receiving medications (primarily methylphenidate) for behavior disorders (primarily hyperactivity) were questioned about widely recommended treatment practices. The results showed that (a) in the majority of cases, pediatricians were responsible for supervising drug therapy; (b) most parents were satisfied with their current physician; and (c) approximately one half of the children had three or more office visits per year. However, teachers were rarely asked to use standardized procedures to evaluate drug response, and direct contact between teacher and physician was all but nonexistent. There was a considerable degree of disagreement between parents and teachers concerning drug efficacy, dosage, and the need for medication; and parents appeared to exert a considerable degree of control over treatment-related decisions. In general, drug-free periods were not scheduled on a regular basis, and evidence for an integrated multimodal treatment approach was lacking. The findings suggest that variables other than a clinically determined response to medication are often the salient elements of the treatment-related decision-making process.

Clinical Pediatrics, Vol. 22, No. 1, 48-53 (1983)
DOI: 10.1177/000992288302200106


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Atten DisordHome page
M. T. Lien, J. S. Carlson, S. Hunter-Oehmke, and K. A. Knapp
A Pilot Investigation of Teachers' Perceptions of Psychotropic Drug Use in Schools
J Atten Disord, September 1, 2007; 11(2): 172 - 177.
[Abstract] [PDF]


Home page
Journal of Emotional and Behavioral DisordersHome page
K. D. Gadow and E. E. Nolan
Practical Considerations in Conducting School-Based Medication Evaluations for Children with Hyperactivity
Journal of Emotional and Behavioral Disorders, April 1, 1993; 1(2): 118 - 126.
[Abstract] [PDF]


Home page
Journal of Special EducationHome page
N. N. Singh, M. H. Epstein, J. Luebke, and Y. N. Singh
Psychopharmacological Intervention I: Teacher Perceptions of Psychotropic Medication for Students with Serious Emotional Disturbance
Journal of Special Education, January 1, 1990; 24(3): 283 - 295.
[Abstract] [PDF]


Home page
J Learn DisabilHome page
K. D. Gadow
Effects of Stimulant Drugs on Academic Performance in Hyperactive and Learning Disabled Children
J Learn Disabil, May 1, 1983; 16(5): 290 - 299.
[Abstract] [PDF]